Ascend Clinical becomes first user of new artificial intelligence renal care solution

SambaNova Systems and DeLorean Artificial Intelligence announced a new subscription artificial intelligence solution that Ascend Clinical has chosen to leverage with learning models, according to a press release.
“We are committed to providing world-class care to our patients, so our laboratories need the most innovative technology," Paul F. Beyer, CEO of Ascend, said in the release. “We’re looking forward to advancing our AI initiatives to provide a higher level of precision and improve our customers’ insights into their own data.”
Ascend intends to use the

SambaNova Systems and DeLorean Artificial Intelligence announced a new subscription artificial intelligence solution that Ascend Clinical has chosen to leverage with learning models, according to a press release.
“We are committed to providing world-class care to our patients, so our laboratories need the most innovative technology,» Paul F. Beyer, CEO of Ascend, said in the release. “We’re looking forward to advancing our AI initiatives to provide a higher level of precision and improve our customers’ insights into their own data.”
Ascend intends to use the